Pediatric Urethral Catheter Supply

The contract seeks the supply of sterile, hydrogel-coated latex pediatric urethral catheters packaged in commercial compliance with all applicable federal medical regulations, ensuring safety and adherence to clinical standards for pediatric use. The items must meet stringent quality and sterility requirements, with packaging designed for direct deployment in healthcare settings without additional preparation. The solicitation, issued under the NAICS code 325620 for medical device manufacturing, is structured as a subcontract and falls under the purview of the Department of Defense's Medical Supply Chain, specifically managed by the MD SURG FSF office. Responses are due by July 27, 2026, with the opportunity posted on July 21, 2026, and all procurement details accessible via the DIBBS portal. The contract does not specify a set-aside designation, indicating eligibility for all qualified suppliers regardless of business size or ownership status. There is no designated point of contact listed, and performance location details are unspecified, implying delivery may be directed to any DoD-affiliated medical facility or distribution hub within the U.S. or its territories. All bidders must ensure full compliance with U.S. federal medical device regulations, including but not limited to FDA requirements for sterility, labeling, and material safety. Submissions must clearly demonstrate the ability to consistently deliver compliant product at scale, with documentation supporting manufacturing processes, quality control protocols, and regulatory registrations for the specified catheter type.